Polymer Capital Management (Us) LLC Sarepta Therapeutics, Inc. Transaction History
Polymer Capital Management (Us) LLC
- $388 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 5,848 shares of SRPT stock, worth $206,258. This represents 0.1% of its overall portfolio holdings.
Number of Shares
5,848Holding current value
$206,258% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
507Shares Held
88.7MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$364 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$320 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$319 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$143 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$119 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.09B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...